SpecialtiesQuestion

How has the POINT trial changed your approach to management of uveitic macular edema?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

In patients with progressive AZOOR who demonstrate enlarging zones of outer retinal loss despite corticosteroid therapy, how do you determine when to escalate to steroid-sparing immunomodulatory agents?

How do you approach the management of a patient with psoriasis and chronic anterior uveitis who is unable to take DMARDs and has tried TNF inhibitors and IL-17 inhibitors but has ongoing bilateral anterior uveitis?

What factors affect/correlate with viral PCR yield in aqueous in a patient with recurrent episodes of uveitis associated with high IOP?

Does a patient's history of non-infectious uveitis in multiple sclerosis influence your recommendations for type of disease-modifying therapy when co-managing with a neurologist?

How do you choose between intravitreal methotrexate versus ocular radiation for isolated retinal relapse in PVRL?

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
Mobile App

Company

About
Careers
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.